tiprankstipranks
Cortexyme Inc (CRTX)
NASDAQ:CRTX
US Market

Cortexyme (CRTX) Income Statement

0 Followers

Cortexyme Income Statement

Last quarter (Q ), Cortexyme's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Cortexyme's net income was $-21.64M. See Cortexyme’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 88.87M$ 90.32M$ 78.89M$ 39.17M$ 12.12M$ 10.37M
Operating Income
$ -88.87M$ -90.32M$ -78.89M$ -39.17M$ -12.12M$ -10.37M
Net Non Operating Interest Income Expense
$ 465.00K$ 620.00K$ 2.04M$ 2.19M$ -151.00K$ -1.64M
Other Income Expense
$ -98.00K$ -247.00K--$ -206.00K$ -222.00K
Pretax Income
$ -88.50M$ -89.94M$ -76.85M$ -36.98M$ -12.48M$ -12.23M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -88.50M$ -89.94M$ -76.85M$ -36.98M$ -12.48M$ -12.23M
Basic EPS
$ -2.97$ -3.03$ -2.63$ -1.94$ -0.58$ -0.57
Diluted EPS
$ -2.97$ -3.03$ -2.63$ -1.94$ -0.58$ -0.57
Basic Average Shares
$ 119.45M$ 29.72M$ 29.18M$ 19.03M$ 21.55M$ 21.55M
Diluted Average Shares
$ 119.45M$ 29.72M$ 29.18M$ 19.03M$ 21.55M$ 21.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 88.87M$ 90.32M$ 78.89M$ 39.17M$ 12.12M$ 10.37M
Net Income From Continuing And Discontinued Operation
$ -88.50M$ -89.94M$ -76.85M$ -36.98M$ -12.48M$ -12.23M
Normalized Income
$ -88.50M$ -89.94M$ -76.85M$ -36.98M$ -12.27M$ -12.01M
Interest Expense
--$ 0.00$ 0.00$ 957.00K$ 1.64M
EBIT
$ -88.87M$ -90.32M$ -78.89M$ -36.98M$ -11.52M$ -10.59M
EBITDA
$ -88.57M$ -89.97M$ -78.56M$ -36.79M$ -11.47M$ -10.55M
Currency in USD

Cortexyme Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis